Mark E Reeves Selected Research

Hepatocellular Carcinoma (Hepatoma)

11/2023	Proton beam radiotherapy versus transarterial chemoembolization for hepatocellular carcinoma: Results of a randomized clinical trial.
5/2016	Randomized Clinical Trial Comparing Proton Beam Radiation Therapy with Transarterial Chemoembolization for Hepatocellular Carcinoma: Results of an Interim Analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mark E Reeves Research Topics

Disease

22	Neoplasms (Cancer) 07/2023 - 05/2004
8	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 04/2024 - 12/2021
7	Neoplasm Metastasis (Metastasis) 08/2021 - 05/2004
6	Lung Neoplasms (Lung Cancer) 01/2019 - 12/2006
5	Adenocarcinoma 03/2023 - 05/2004
3	Hematologic Neoplasms (Hematological Malignancy) 01/2023 - 01/2020
3	Noninfiltrating Intraductal Carcinoma (DCIS) 11/2017 - 10/2013
2	Hepatocellular Carcinoma (Hepatoma) 11/2023 - 05/2016
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2023 - 01/2023
2	COVID-19 08/2022 - 01/2020
2	Leukemia 01/2021 - 01/2020
2	Osteosarcoma (Osteogenic Sarcoma) 01/2021 - 01/2020
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2020 - 11/2019
2	Melanoma (Melanoma, Malignant) 10/2019 - 01/2003
2	Stomach Neoplasms (Stomach Cancer) 08/2018 - 02/2018
2	Colonic Neoplasms (Colon Cancer) 07/2018 - 02/2007
2	Colorectal Neoplasms (Colorectal Cancer) 01/2018 - 01/2018
2	Carcinoma (Carcinomatosis) 11/2017 - 10/2016
2	Carcinogenesis 05/2017 - 07/2016
1	Merkel Cell Carcinoma 01/2024
1	Basosquamous Carcinoma 02/2023
1	Pancreatic Neoplasms (Pancreatic Cancer) 08/2022
1	Sarcoma (Soft Tissue Sarcoma) 10/2020
1	Pneumonia (Pneumonitis) 01/2020
1	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2020
1	Communicable Diseases (Infectious Diseases) 01/2020
1	Cytokine Release Syndrome 01/2020
1	Human Influenza (Influenza) 01/2020
1	Infections 01/2020
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 11/2019
1	Acute Kidney Injury (Acute Renal Failure) 10/2016
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 07/2016
1	Mitochondrial Diseases (Mitochondrial Disease) 07/2016
1	Pathologic Complete Response 05/2016

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 11/2020 - 12/2006
4	Protons (Proton)IBA 11/2023 - 05/2016
3	RNA (Ribonucleic Acid)IBA 03/2023 - 05/2017
3	Vitamin D FDA LinkGeneric 05/2022 - 01/2020
2	Biomarkers (Surrogate Marker)IBA 07/2023 - 03/2023
2	MicroRNAs (MicroRNA)IBA 03/2023 - 01/2019
2	Piwi-Interacting RNAIBA 01/2019 - 05/2017
2	Protein Isoforms (Isoforms)IBA 07/2016 - 01/2014
2	Small Interfering RNA (siRNA)IBA 05/2012 - 12/2006
2	Messenger RNA (mRNA)IBA 10/2010 - 12/2006
1	duocarmycin SAIBA 04/2024
1	B7-H1 AntigenIBA 07/2023
1	Small Cytoplasmic RNAIBA 03/2023
1	2-Oxoglutarate 5-Dioxygenase Procollagen-Lysine (Lysyl Hydroxylase)IBA 01/2023
1	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 01/2023
1	CollagenIBA 01/2023
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2023
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2023
1	Tyrosine Kinase InhibitorsIBA 01/2023
1	Immunoglobulin G (IgG)IBA 08/2022
1	AntibodiesIBA 08/2022
1	Capecitabine (Xeloda)FDA Link 08/2022
1	ErbB Receptors (EGF Receptor)IBA 08/2022
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 08/2022
1	Gemcitabine FDA Link 08/2022
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 08/2022
1	CytokinesIBA 04/2022
1	fms-Like Tyrosine Kinase 3IBA 04/2022
1	Lidocaine (Xylocaine)FDA LinkGeneric 01/2021
1	Oncogene Proteins (Oncogene Protein)IBA 01/2021
1	Bupivacaine (Bupivacaine Hydrochloride)FDA LinkGeneric 01/2021
1	Phosphotransferases (Kinase)IBA 01/2021
1	Nerve Growth Factors (Neurotrophins)IBA 01/2020
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2020
1	CateninsIBA 01/2020
1	NF-kappa B (NF-kB)IBA 01/2020
1	Interleukin-6 (Interleukin 6)IBA 01/2020
1	silmitasertibIBA 01/2020
1	Nerve Growth Factor (NGF)IBA 01/2020
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020
1	Casein Kinase II (Casein Kinase 2)IBA 01/2020
1	Methylnitronitrosoguanidine (MNNG)IBA 01/2020
1	Indomethacin (Indometacin)FDA LinkGeneric 01/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020
1	Transcription Factors (Transcription Factor)IBA 11/2019
1	Bevacizumab (Avastin)FDA Link 01/2018
1	Cetuximab (Erbitux)FDA Link 01/2018
1	Estrogen ReceptorsIBA 11/2017
1	IntegrinsIBA 07/2016
1	Betulinic AcidIBA 01/2014
1	Insulin-Like Growth Factor Binding Protein 5IBA 01/2014

Therapy/Procedure

10	Therapeutics 07/2023 - 02/2007
9	Drug Therapy (Chemotherapy) 01/2023 - 05/2004
5	Radiotherapy 11/2023 - 02/2019
4	Immunotherapy 01/2023 - 10/2019
2	Gastrectomy 08/2018 - 02/2018
2	Adjuvant Chemotherapy 08/2018 - 07/2018
2	Adjuvant Chemoradiotherapy 08/2018 - 02/2018
1	Adjuvant Radiotherapy 01/2024
1	Precision Medicine 01/2021
1	Immunomodulation 01/2020
1	Biological Therapy 01/2018
1	Mastectomy (Mammectomy) 10/2016
1	Ileostomy 10/2016
1	Simple Mastectomy 10/2016
1	Proton Therapy 05/2016